THE EFFECT OF DRUG THERAPY IN PATIENTS WITH OBESITY ON THE CLINICAL MANIFESTATIONS OF KNEE OSTEOARTHRITIS

Authors

  • S. B. Kholbayev Samarkand State Medical Institute, Republic of Uzbekistan, Samarkand
  • Sh. A. Yusupov Samarkand State Medical Institute, Republic of Uzbekistan, Samarkand
  • N. E. Yuldashova Samarkand State Medical Institute, Republic of Uzbekistan, Samarkand
  • N. E. Sulaymanova Samarkand State Medical Institute, Republic of Uzbekistan, Samarkand

DOI:

https://doi.org/10.11603/1811-2471.2020.v.i1.11085

Keywords:

osteoarthritis, overweight patients, orlistat

Abstract

The effect of orlistat therapy on the clinical manifestations of osteoarthrosis (OA) of the knee joints in patients suffering from obesity at the site of a general practitioner is considered in the article.

The aim – assessment of the effect of weight loss on the background of orlistat administration on clinical manifestations of OA of knee joints in women with overweight.

Material and Methods. The study involved 5 general practitioners and 50 patients with symptomatic OA that met the criteria of the American College of Rheumatologists (ACR).

The WOMAC questionnaire was used to determine the effectiveness of the therapy. The evaluation was performed by VAS in millimeters. Quality of life (patient health) was determined by VAS questionnaire EQ-5D. Patients were evaluated for adverse reactions during the observation period. Data processing was performed using descriptive statistics methods.

Results. Orlistat obesity therapy has the potential to achieve clinically significant reductions (≥5 %). Weight loss when taking special drugs in patients with obesity and OA of the knee joints is accompanied by a decrease in pain and improvement in the functional state of knee joints, which has a positive effect on the quality of life of patients.

Conclusions. Weight loss, in patients with high body mass index and OA of the knee joints, especially when taking drugs that contribute to its reduction, leads to regression of clinical manifestations of gonarthrosis: reducing pain and improving functional status. In this regard, drugs that contribute to weight loss, should be included in the scheme of treatment of patients with OA and obesity.

References

Ametov, A.S., & Doskina, E.V. (2011). Ozhirenie i sovremennye metody lecheniya: Lektsiya dlya vrachei [Obesity and modern methods of treatment: A lecture for doctors]. Moscow: RMAPO [in Russian].

Toivanen, A.T., Heliövaara, M., & Impivaara, O. (2010). Obesity, physically demanding work and traumatic knee injury are major risk factors for knee osteoarthritis – a population-based study with a follow-up of 22 years. Rheumatology (Oxford), 49 (2), 308-314. DOI: 10.1093/rheumatology/kep388. DOI: https://doi.org/10.1093/rheumatology/kep388

Lohmander, L.S., Gerhardsson de Verdier, M., & Rollof, J. (2009). Incidence of severe knee and hip osteoarthritis in relation to different measures of body mass: a population-based prospective cohort study. Ann. Rheum. Dis., 68 (4), 490-496. DOI: 10.1136/ard.2008.089748 DOI: https://doi.org/10.1136/ard.2008.089748

Felson, D.T., Lawrence, R.C., & Dieppe, P.A. (2000). Osteoarthritis: new insights. Part 1: The disease and its risk factors FREE. Ann. Intern. Med., 133 (8), 635-646. DOI:10.7326/0003-4819-133-8-200010170-00016 DOI: https://doi.org/10.7326/0003-4819-133-8-200010170-00016

Reijman, M., Pols, H., & Bergink, A.P. (2007). Body mass index associated with onset and progression of osteoarthritis of the knee but not of the hip: The Rotterdam Study. Ann. Rheum. Dis., 66, 158-162. doi: 10.1136/ard.2006.053538. DOI: https://doi.org/10.1136/ard.2006.053538

Cimmino, M.A., Scarpa, R., & Caporali, R. (2013). Body mass and osteoarthritic pain: results from a study in general practice. Clin. Exp. Rheumatol., 31 (6), 843-849.

Marks, R. (2007). Obesity profiles with knee osteoarthritis: correlation with pain, disability, disease progression. Obesity (Silver Spring), 15 (7), 1867-1874. DOI: 10.1038/oby.2007.221 DOI: https://doi.org/10.1038/oby.2007.221

Tanamas, S.K., & Wluka, A.E. (2013). Association of weight gain with incident knee pain, stiffness, and functional dificulties: A longitudinal study. Arthr. Care Res., 65 (1), 34-43. DOI: 10.1002/acr.21745 DOI: https://doi.org/10.1002/acr.21745

Zhang, W., Nuki, G., & Moskowitz, R.W. (2010). OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthr. Cartilage, 18 (4), 476-499. DOI: 10.1016/j.joca.2010.01.013 DOI: https://doi.org/10.1016/j.joca.2010.01.013

(1998). National Institutes of Health, National Heart Lung and Blood Institute. Evaluation, and Treatment of Overweight and Obesity in Adults. Clinical Guidelines on the Identification.

Riddle, D.L., & Stratford, P.W. (2013). Body weight changes and corresponding changes in pain and function in persons with symptomatic knee osteoarthritis: A cohort study. Arthr. Care Res., 65 (1), 15-22. DOI: 10.1002/acr.21692 DOI: https://doi.org/10.1002/acr.21692

Messier, S.P., Mihalko, S.L., & Legault, C. (2013). Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis: the IDEA randomized clinical trial. JAMA, 310(12),1263-1273. DOI: 10.1001/jama.2013.277669 DOI: https://doi.org/10.1001/jama.2013.277669

Tsigosa, C., Hainerb, V., & Basdevantc, A. (2008). Management of Obesity in Adults: European Clinical Practice Guidelines. Obesity Facts, 1, 106-116. DOI: 10.1159/000126822 DOI: https://doi.org/10.1159/000126822

Bondarenko, I.Z., Butrova, S.A., & Goncharov, N.P. (2011). Lecheniye komorbidnogo ozhyreniye. Natsionalnye klinicheskiye rekomendatsii [Treatment of morbid obesity. National clinical guidelines]. Ozhirenie i metabolism – Obesity and Metabolism, 3, 75-83 [in Russian].

Toplak, H., Ziegler, O., & Keller, U. (2005). X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet. Early response to treatment predicts weight maintenance. Diabetes Obes. Metab., 7, 699-708. DOI: 10.1111/j.1463 1326.2005.00483.x

Finer, N., James, W.P.T., & Kopelman, P.G. (2000). One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicenter study of orlistat, a gastrointestinal lipase inhibitor. Int. J. Obes. Relat. Metab. Disord., 24, 306-313. DOI: 10.1038/sj.ijo.0801128 DOI: https://doi.org/10.1038/sj.ijo.0801128

Altman, R., Alarcon, G., & Appelrouth, D. (1991). The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum., 34, 505-514. DOI: 10.1002/art.1780340502 DOI: https://doi.org/10.1002/art.1780340502

Published

2020-05-06

How to Cite

Kholbayev, S. B., Yusupov, S. A., Yuldashova, N. E., & Sulaymanova, N. E. (2020). THE EFFECT OF DRUG THERAPY IN PATIENTS WITH OBESITY ON THE CLINICAL MANIFESTATIONS OF KNEE OSTEOARTHRITIS. Achievements of Clinical and Experimental Medicine, (1), 181–187. https://doi.org/10.11603/1811-2471.2020.v.i1.11085

Issue

Section

Оригінальні дослідження